Regeneron Pharmaceuticals, Inc.
REGNNasdaqCIK 872589HealthcareFiscal year ends Dec 31
Reports and events: 327 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3006:55 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000872589-26-000034 |
| 2026-10-3006:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000032 |
| 2026-10-0607:51 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001104659-26-113895 |
| 2026-09-3016:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-112340 |
| 2026-07-3006:52 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000872589-26-000025 |
| 2026-07-3006:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000023 |
| 2026-07-0607:00 ET | 8-K | 2.02 Results of operations | 0001104659-26-080562 |
| 2026-06-1716:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-075127 |
| 2026-04-2906:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000872589-26-000016 |
| 2026-04-2906:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000014 |
| 2026-04-2416:02 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001308179-26-000340 |
| 2026-04-0807:05 ET | 8-K | 2.02 Results of operations | 0001104659-26-040661 |
| 2026-02-0409:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000872589-26-000008 |
| 2026-01-3006:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000004 |
| 2026-01-1206:48 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002691 |
| 2025-10-2806:56 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000872589-25-000028 |
| 2025-10-2806:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-25-000026 |
| 2025-10-0607:00 ET | 8-K | 2.02 Results of operations | 0001104659-25-096921 |
| 2025-08-0106:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000872589-25-000019 |
| 2025-08-0106:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-25-000017 |
| 2025-06-1816:12 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-060637 |
| 2025-04-2906:51 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001804220-25-000022 |
| 2025-04-2906:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-25-000020 |
| 2025-04-2906:03 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0001308179-25-000518 |
| 2025-02-0509:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001804220-25-000011 |
| 2025-02-0407:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001804220-25-000007 |
| 2025-01-1306:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002826 |
| 2024-10-3107:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001804220-24-000040 |
| 2024-10-3107:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000038 |
| 2024-10-0707:00 ET | 8-K | 2.02 Results of operations | 0001104659-24-106432 |
| 2024-08-0107:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001804220-24-000028 |
| 2024-08-0107:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000026 |
| 2024-07-0807:00 ET | 8-K | 2.02 Results of operations | 0001104659-24-078172 |
| 2024-06-2016:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-073372 |
| 2024-05-0207:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001804220-24-000017 |
| 2024-05-0207:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000015 |
| 2024-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0001308179-24-000577 |
| 2024-02-0509:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001804220-24-000009 |
| 2024-02-0207:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000006 |
| 2024-01-3116:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-008807 |
| 2024-01-0806:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002037 |
| 2023-11-0207:22 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001804220-23-000031 |
| 2023-11-0207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000029 |
| 2023-10-0516:04 ET | 8-K | 2.02 Results of operations | 0001104659-23-107161 |
| 2023-09-2716:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-104277 |
| 2023-09-0817:00 ET | 8-K/A | 5.07 Shareholder vote results | 0001104659-23-099351 |
| 2023-09-0816:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-099345 |
| 2023-08-1817:16 ET | SC 13D | Ownership report, active investor | 0001104659-23-093555 |
| 2023-08-0306:56 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001804220-23-000023 |
| 2023-08-0306:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000021 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:29 ET. Listed shows no prices and gives no investment advice.